Clinical Trial Detail

NCT ID NCT00550992
Title Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Dutch Childhood Oncology Group
Indications

acute lymphocytic leukemia

Therapies

Busulfan

Melphalan

Mercaptopurine

Cytarabine + Etoposide + Mitoxantrone

Cyclophosphamide + Methotrexate + Pegaspargase + Vincristine

Thioguanine

Cyclosporine

anti-thymocyte globulin

Daunorubicin

Leucovorin

Age Groups: child

Additional content available in CKB BOOST